참고문헌 (50)

1. 1 Alkema NG , Wisman GB , van der Zee AG , van Vugt MA , de Jong S . Studying platinum sensitivity and resistance in high‐grade serous ovarian cancer: different models for different questions . Drug Resist Update 2016 ; 24 : 55 – 69 . 

2. 2 Ferreira JA , Peixoto A , Neves M et al Mechanisms of cisplatin resistance and targeting of cancer stem cells: adding glycosylation to the equation . Drug Resist Update 2016 ; 24 : 34 – 54 . 

3. 3 Gatti L , Cassinelli G , Zaffaroni N , Lanzi C , Perego P . New mechanisms for old drugs: insights into DNA‐unrelated effects of platinum compounds and drug resistance determinants . Drug Resist Update 2015 ; 20 : 1 – 11 . 

4. 4 Yu H , Su J , Xu Y et al p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins . Eur J Cancer 2011 ; 47 : 1585 – 94 . 21371883 

   상세보기

5. 5 Moscat J , Karin M , Diaz‐Meco M . p62 in cancer: signaling adaptor beyond autophagy . Cell 2016 ; 167 : 606 – 9 . 27768885 

   상세보기

6. 6 Katsuragi Y , Ichimura Y , Komatsu M . p62/SQSTM1 functions as a signaling hub and an autophagy adaptor . FEBS J 2015 ; 282 : 4672 – 8 . 26432171 

   상세보기

7. 7 Moscat J , Diaz‐Meco MT . p62 at the crossroads of autophagy, apoptosis, and cancer . Cell 2009 ; 137 : 1001 – 4 . 19524504 

   상세보기

8. 8 Moscat J , Diaz‐Meco MT . p62: a versatile multitasker takes on cancer . Trends Biochem Sci 2012 ; 37 : 230 – 6 . 22424619 

   상세보기

9. 9 Zhang J , Yang Z , Dong J . P62: an emerging oncotarget for osteolytic metastasis . J Bone Oncol 2016 ; 5 : 30 – 7 . 26998424 

10. 10 Xia M , Yu H , Gu S et al p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1‐Nrf2‐ARE system . Int J Oncol 2014 ; 45 : 2341 . 25269472 

    상세보기

11. 11 Puvirajesinghe TM , François B , Ashish J et al Identification of p62/SQSTM1 as a component of non‐canonical Wnt VANGL2–JNK signalling in breast cancer . Nat Comm 2016 ; 7 : 10318 . 

12. 12 Saito T , Ichimura Y , Taguchi K et al p62/Sqstm1 promotes malignancy of HCV‐positive hepatocellular carcinoma through Nrf2‐dependent metabolic reprogramming . Nat Comm 2016 ; 7 : 12030 . 

13. 13 Chen K , Zeng J , Xiao H et al Regulation of glucose metabolism by p62/SQSTM1 through HIF1α . J Cell Sci 2016 ; 129 : 817 – 30 . 26743088 

    상세보기

14. 14 Iwadate R , Inoue J , Tsuda H et al High expression of SQSTM1/p62 protein is associated with poor prognosis in epithelial ovarian cancer . Acta Histochem Cytochem 2014 ; 47 : 295 – 301 . 25859063 

    상세보기

15. 15 Duran A , Linares JF , Galvez AS et al The signaling adaptor p62 is an important NF‐kappaB mediator in tumorigenesis . Cancer Cell 2008 ; 13 : 343 – 54 . 18394557 

16. 16 Trocoli A , Bensadoun P , Richard E et al p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells . Cell Death Differ 2014 ; 21 : 1852 – 61 . 25034783 

    상세보기

17. 17 Manley S , Williams JA , Ding WX . Role of p62/SQSTM1 in liver physiology and pathogenesis . Exp Biol Med 2013 ; 238 : 525 – 38 . 

18. 18 Xi G , Shen X , Wai C , Vilas CK , Clemmons DR . Hyperglycemia stimulates p62/PKCζ interaction, which mediates NF‐κB activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle . FASEB J 2015 ; 29 . 

19. 19 Ofengeim D , Yuan J . Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death . Nat Rev Mol Cell Biol 2013 ; 14 : 727 – 36 . 24129419 

    상세보기

20. 20 Liu XY , Lai F , Yan XG et al RIP1 kinase is an oncogenic driver in melanoma . Cancer Res 2015 ; 75 : 1736 – 48 . 25724678 

    상세보기

21. 21 Lin Y . RIP1‐mediated signaling pathways in cell survival and death . Control 2014 ; 23 – 43 . 

22. 22 de Almagro MC , Goncharov T , Izraeltomasevic A et al Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death . Cell Death Diff 2017 ; 24 : 26 – 37 . 

23. 23 Li H , Kobayashi M , Blonska M , You Y , Lin X . Ubiquitination of RIP is required for tumor necrosis factor alpha‐induced NF‐kappaB activation . J Biol Chem 2006 ; 281 : 13636 – 43 . 16543241 

    상세보기

24. 24 Yang Y , Xia F , Hermance N et al A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF‐kappaB and p38 mitogen‐activated protein kinase (MAPK)/MAPK‐activated protein 2 responses to DNA damage . Mol Cell Biol 2011 ; 31 : 2774 – 86 . 21606198 

25. 25 Emmerich CH , Ordureau A , Strickson S et al Activation of the canonical IKK complex by K63/M1‐linked hybrid ubiquitin chains . Proc Natl Acad Sci USA 2013 ; 110 : 15247 – 52 . 23986494 

    상세보기

26. 26 Sanz L , Sanchez P , Lallena MJ , Diaz‐Meco MT , Moscat J . The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation . EMBO J 1999 ; 18 : 3044 – 53 . 10356400 

    상세보기

27. 27 Ma L , Xu Y , Su J et al Autophagic flux promotes cisplatin resistance in human ovarian carcinoma cells through ATP‐mediated lysosomal function . Int J Oncol 2015 ; 47 : 1890 . 26397057 

    상세보기

28. 28 Hayden MS , Ghosh S . Shared principles in NF‐kappaB signaling . Cell 2008 ; 132 : 344 – 62 . 18267068 

29. 29 Demchenko YN , Glebov OK , Zingone A , Keats JJ , Bergsagel PL , Kuehl WM . Classical and/or alternative NF‐kappaB pathway activation in multiple myeloma . Blood 2010 ; 115 : 3541 – 52 . 20053756 

30. 30 Viatour P , Merville MP , Bours V , Chariot A . Phosphorylation of NF‐kappaB and IkappaB proteins: implications in cancer and inflammation . Trends Biochem Sci 2005 ; 30 : 43 – 52 . 15653325 

31. 31 Salic A , Mitchison TJ . A chemical method for fast and sensitive detection of DNA synthesis in vivo . Proc Natl Acad Sci USA 2008 ; 105 : 2415 – 20 . 18272492 

    상세보기

32. 32 Flomerfelt FA , Gress RE . Analysis of cell proliferation and homeostasis using EdU labeling . Methods Mol Biol 2016 ; 1323 : 211 – 20 . 26294411 

    상세보기

33. 33 Zhang L , Shao L , Creighton CJ et al Function of phosphorylation of NF‐kB p65 ser536 in prostate cancer oncogenesis . Oncotarget 2015 ; 6 : 6281 – 94 . 25749044 

    상세보기

34. 34 Galluzzi L , Vitale I , Michels J et al Systems biology of cisplatin resistance: past, present and future . Cell Death Dis 2014 ; 5 : e1257 . 24874729 

    상세보기

35. 35 Gottesman MM . Mechanisms of cancer drug resistance . Medicine 2002 ; 53 : 615 – 27 . 

36. 36 Safaei R , Larson BJ , Cheng TC et al Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug‐resistant human ovarian carcinoma cells . Mol Cancer Ther 2005 ; 4 : 1595 – 604 . 16227410 

    상세보기

37. 37 Kelland L . The resurgence of platinum‐based cancer chemotherapy . Nat Rev Cancer 2007 ; 7 : 573 – 84 . 17625587 

    상세보기

38. 38 Wei H , Guan JL . Blocking tumor growth by targeting autophagy and SQSTM1 in vivo . Autophagy 2015 ; 11 : 854 – 5 . 26020424 

    상세보기

39. 39 Nakamura K , Kimple AJ , Siderovski DP , Johnson GL . PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF‐kappaB activation . J Biol Chem 2010 ; 285 : 2077 – 89 . 19903815 

40. 40 Moscat J , Diaz‐Meco MT , Wooten MW . Signal integration and diversification through the p62 scaffold protein . Trends Biochem Sci 2007 ; 32 : 95 – 100 . 17174552 

    상세보기

41. 41 Yang YI , Ahn JH , Lee KT , Shih Ie M , Choi JH . RSF1 is a positive regulator of NF‐kappaB‐induced gene expression required for ovarian cancer chemoresistance . Cancer Res 2014 ; 74 : 2258 – 69 . 24566868 

42. 42 Annunziata CM , Stavnes HT , Kleinberg L et al Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer . Cancer 2010 ; 116 : 3276 – 84 . 20564628 

43. 43 Puliyappadamba VT , Chakraborty S , Chauncey SS et al Opposing effect of EGFRWT on EGFRvIII‐mediated NF‐kappaB activation with RIP1 as a cell death switch . Cell Rep 2013 ; 4 : 764 – 75 . 23972990 

44. 44 Wu P , Shi KJ , An JJ et al The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite‐treated colorectal cancer cells . Cell Death Dis 2014 ; 5 : e1085 . 24577083 

    상세보기

45. 45 Rosebeck S , Rehman AO , Apel IJ et al The API2‐MALT1 fusion exploits TNFR pathway‐associated RIP1 ubiquitination to promote oncogenic NF‐kappaB signaling . Oncogene 2014 ; 33 : 2520 – 30 . 23770847 

46. 46 Bellail AC , Olson JJ , Yang X , Chen ZJ , Hao C . A20 ubiquitin ligase‐mediated polyubiquitination of RIP1 inhibits caspase‐8 cleavage and TRAIL‐induced apoptosis in glioblastoma . Cancer Discov 2012 ; 2 : 140 – 55 . 22585859 

    상세보기

47. 47 Teramachi J , Silbermann R , Yang P et al Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma‐bearing bones in vivo . Leukemia 2016 ; 30 : 390 – 8 . 26286116 

    상세보기

48. 48 Huang S , Okamoto K , Yu C , Sinicrope FA . p62/sequestosome‐1 up‐regulation promotes ABT‐263‐induced caspase‐8 aggregation/activation on the autophagosome . J Biol Chem 2013 ; 288 : 33654 – 66 . 24121507 

    상세보기

49. 49 Zeng RX , Zhang YB , Fan Y , Wu GL . p62/SQSTM1 is involved in caspase‐8 associated cell death induced by proteasome inhibitor MG132 in U87MG cells . Cell Biol Int 2014 ; 38 : 1221 – 6 . 24805111 

    상세보기

50. 50 Wong WW , Silke J . Another facet of ubiquitylation: death . J Mol Cell Biol 2009 ; 1 : 80 – 1 . 19797318 

    상세보기